220 related articles for article (PubMed ID: 32367704)
21. Anterior chamber migration of intravitreal dexamethasone implant in glued intraocular lens.
Kumar DA; Dhawan A; Narayanan S; Agarwal A
Indian J Ophthalmol; 2019 Feb; 67(2):268-269. PubMed ID: 30672486
[No Abstract] [Full Text] [Related]
22. Use of intravitreal dexamethasone implant in patients with cataract and macular edema undergoing phacoemulsification.
Sze AM; Luk FO; Yip TP; Lee GK; Chan CK
Eur J Ophthalmol; 2015; 25(2):168-72. PubMed ID: 25363857
[TBL] [Abstract][Full Text] [Related]
23. Management of Anterior Chamber Migration of Dexamethasone Intravitreal Implant.
Ha JY; Jang JY; Ji YS
Korean J Ophthalmol; 2017 Dec; 31(6):574-575. PubMed ID: 29230981
[No Abstract] [Full Text] [Related]
24. Inadvertent dexamethasone implant injection into the lens body management.
Berarducci A; Sian IS; Ling R
Eur J Ophthalmol; 2014; 24(4):620-2. PubMed ID: 24519508
[TBL] [Abstract][Full Text] [Related]
25. Anterior segment migration of dexamethasone implant: risk factors, complications, and management.
Rahimy E; Khurana RN
Curr Opin Ophthalmol; 2017 May; 28(3):246-251. PubMed ID: 28376511
[TBL] [Abstract][Full Text] [Related]
26. Intracapsular dexamethasone implant in patients undergoing phacoemulsification and intraocular lens implantation.
Vianna LM; Freitas LL; Nosé W; Kanecadan LA; Soriano ES; Muccioli C; Belfort R
Arq Bras Oftalmol; 2013; 76(4):226-8. PubMed ID: 24061833
[TBL] [Abstract][Full Text] [Related]
27. Pars plana vitrectomy and re-directing a dexamethasone implant into vitreous cavity following misdirected entry into the crystalline lens.
Biswas P; Nandi K; Batra S; Ginodia A; Biswas P
Indian J Ophthalmol; 2018 Jul; 66(7):1033-1036. PubMed ID: 29941766
[TBL] [Abstract][Full Text] [Related]
28. Removal of a migrated dexamethasone implant (Ozurdex) from the anterior chamber using an intravenous cannula.
Ku JY; Mercieca K; Yau K
BMJ Case Rep; 2021 Jul; 14(7):. PubMed ID: 34244184
[TBL] [Abstract][Full Text] [Related]
29. [Migration of an intravitreal dexamethasone implant into the anterior chamber in contact with an anterior chamber intraocular lens].
Callet M; Sampo M; Hugo J; Speybrouck-Grebert A; Hoffart L
J Fr Ophtalmol; 2018 Mar; 41(3):e107-e109. PubMed ID: 29395594
[No Abstract] [Full Text] [Related]
30. Modified No-Touch Technique for Removal of a Dexamethasone Implant that has Migrated to the Anterior Chamber.
Stewart JM
Ocul Immunol Inflamm; 2020; 28(2):238-239. PubMed ID: 30556778
[TBL] [Abstract][Full Text] [Related]
31. Intravitreal Dexamethasone Implant for the Treatment of Postoperative Macular Edema.
Klamann A; Böttcher K; Ackermann P; Geerling G; Schargus M; Guthoff R
Ophthalmologica; 2016; 236(4):181-185. PubMed ID: 27915343
[TBL] [Abstract][Full Text] [Related]
32. Simple technique for management of anterior chamber-migrated Ozurdex
Lee SH; Kang H; Byeon SH; Kim SS; Koh HJ; Lee SC; Kim M
Acta Ophthalmol; 2018 Nov; 96(7):e893-e894. PubMed ID: 29030918
[No Abstract] [Full Text] [Related]
33. Dexamethasone intravitreal implant for treatment of diabetic macular edema in vitrectomized patients.
Boyer DS; Faber D; Gupta S; Patel SS; Tabandeh H; Li XY; Liu CC; Lou J; Whitcup SM;
Retina; 2011 May; 31(5):915-23. PubMed ID: 21487341
[TBL] [Abstract][Full Text] [Related]
34. Anterior chamber bleeding due to intravitreal dexamethasone implant sclerotomy without vitreous hemorrhage.
Landini L; Boscia G; Sborgia G; Grassi MO; Buonamassa R; Viggiano P; Bisceglia G; Alessio G; Boscia F
Eur J Ophthalmol; 2024 Jan; 34(1):NP96-NP99. PubMed ID: 37254464
[TBL] [Abstract][Full Text] [Related]
35. Dexamethasone implant migration in an eye with congenital glaucoma: A case report and review of the literature.
Chang SM; St Peter DM; Im LT; Munir WM; Schocket LS
Eur J Ophthalmol; 2022 Sep; 32(5):NP46-NP50. PubMed ID: 33781105
[TBL] [Abstract][Full Text] [Related]
36. Spontaneous Dissociation of Fluocinolone Acetonide Sustained Release Implant (Retisert) with Dislocation into the Anterior Chamber.
Chang PY; Kresch Z; Samson CM; Gentile RC
Ocul Immunol Inflamm; 2015; 23(6):454-7. PubMed ID: 24724735
[TBL] [Abstract][Full Text] [Related]
37. The Use of Ozurdex (Dexamethasone Intravitreal Implant) During Anterior Segment Surgery in Patients with Chronic Recurrent Uveitis.
Ragam AP; Kolomeyer AM; Nayak NV; Chu DS
J Ocul Pharmacol Ther; 2015; 31(6):344-9. PubMed ID: 26061893
[TBL] [Abstract][Full Text] [Related]
38. Intravitreal dexamethasone implant for macular edema following uncomplicated phacoemulsification.
Furino C; Boscia F; Recchimurzo N; Sborgia C; Alessio G
Eur J Ophthalmol; 2014; 24(3):387-91. PubMed ID: 24170523
[TBL] [Abstract][Full Text] [Related]
39. Safety and efficacy of dexamethasone intravitreal implant (Ozurdex) for the treatment of persistent macular edema secondary to retinal vein occlusion in eyes previously treated with anti-vascular endothelial growth factors.
Tservakis I; Koutsandrea C; Papaconstantinou D; Paraskevopoulos T; Georgalas I
Curr Drug Saf; 2015; 10(2):145-51. PubMed ID: 25092480
[TBL] [Abstract][Full Text] [Related]
40. OBSERVATION: FLUOCINOLONE ACETONIDE (ILUVIEN) IMPLANT MIGRATION INTO THE ANTERIOR CHAMBER.
Papastavrou VT; Zambarakji H; Dooley I; Eleftheriadis H; Jackson TL
Retin Cases Brief Rep; 2017 Winter; 11(1):44-46. PubMed ID: 26909535
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
